Han Yunfeng, Lai Xuan, Zhang Hua, Yang Jun, Wang Tao
Department of Neurosurgery, Peking University Third Hospital, Beijing, 100191, China.
Department of Geriatrics, Peking University Third Hospital, Beijing, 100191, China.
Neurosurg Rev. 2025 Mar 31;48(1):338. doi: 10.1007/s10143-025-03467-4.
Neutrophil to lymphocyte ratio (NLR) is a biomarker which is related with inflammation and atherosclerosis. Higher NLR is associated with vulnerability of carotid atherosclerotic plaques. Covert brain infarction (CBI) following carotid endarterectomy (CEA) indicates poor prognosis in cognization. In this study, we aimed to investigate the relationship between NLR and CBI in patients who accepted CEA.
In this observational and retrospective cohort study, 333 patients who underwent CEA due to severe carotid artery stenosis were enrolled. NLR was acquired from routine blood tests upon admission. Postoperative CBI was detected on magnetic resonance imaging. Logistic regression analysis was used to examine the association between NLR and CBI.
Patients with CBI had higher NLR (CBI patients: 2.45[1.76-3.58] vs. non-CBI patients: 2.31[1.82-2.88]; P = 0.05). NLR is a strong independent factor predicting the risk of CBI following CEA (odds ratio [OR], 1.740; 95% confidence interval [CI]: 1.325-2.286; P < 0.001). Furthermore, the predictive risk value by NLR is not affected by other related factors.
NLR is associated with the risk of CBI in patients underwent CEA. NLR is a convenient and low-cost biomarker that can be used for risk stratification management of perioperative carotid stenosis patients.
中性粒细胞与淋巴细胞比值(NLR)是一种与炎症和动脉粥样硬化相关的生物标志物。较高的NLR与颈动脉粥样硬化斑块的易损性相关。颈动脉内膜剥脱术(CEA)后发生的隐匿性脑梗死(CBI)提示认知预后不良。在本研究中,我们旨在探讨接受CEA治疗的患者中NLR与CBI之间的关系。
在这项观察性回顾性队列研究中,纳入了333例因严重颈动脉狭窄而接受CEA治疗的患者。入院时通过常规血液检查获取NLR。术后通过磁共振成像检测CBI。采用逻辑回归分析来检验NLR与CBI之间的关联。
发生CBI的患者具有更高的NLR(CBI患者:2.45[1.76 - 3.58] vs. 非CBI患者:2.31[1.82 - 2.88];P = 0.05)。NLR是预测CEA后发生CBI风险的一个强有力的独立因素(比值比[OR],1.740;95%置信区间[CI]:1.325 - 2.286;P < 0.001)。此外,NLR的预测风险值不受其他相关因素的影响。
NLR与接受CEA治疗患者发生CBI的风险相关。NLR是一种方便且低成本的生物标志物,可用于围手术期颈动脉狭窄患者的风险分层管理。